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Koufman and colleagues discovered that the prevalence of reflux in voice disorders may be as high as 60%. 2 Whether esophageal or laryngeal injury occurs is dependent upon the potency of the refluxate and the duration of the mucosal exposure. 3 Distinguishing LPR from GERD Patients with LPR have different symptoms and a different pathophysiologic mechanism than do patients with GERD. The most significant difference is that the majority of patients with LPR do not have esophagitis or heartburn. In numerous studies, the incidence of heartburn in patients with LPR is less than 40%, and the incidence of esophagitis is approximately 25%. 4 Patients with LPR predominantly have daytime or upright reflux; those with GERD have nocturnal or supine reflux. Dysmotility and prolonged esophageal acid exposure occurs with GERD, while intermittent episodes of reflux are characteristics of LPR. Lower esophageal sphincter dysfunction is generally present with GERD, whereas patients with LPR are likely to have upper esophageal sphincter dysfunction. 3 The larynx also differs from the esophagus in its response to reflux in that the larynx lacks the extrinsic and intrinsic epithelial defenses present in the esophagus. The mucosa of the larynx is thin and fragile and cannot protect itself against gastric acids.
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These differences in mechanism account for the differences in symptoms and response to treatment.
Clinical presentation
The most common symptom of LPR is reflux laryngitis: Hoarseness is found in 71% of affected patients.
excessive mucus in the throat, and postnasal drip. These symptoms come from the mucosal irritation associated with LPR ---most patients do not have sinus disease. 4, 6 These common symptoms can complicate the diagnosis of LPR and delay appropriate treatment. Laryngeal spasm or paradoxical vocal fold movements may suggest LPR as an underlying disorder.
Diagnosis
Flexible laryngoscopy or mirror examination by an otolaryngologist is recommended for patients whose history suggests LPR. These procedures are easily done in the office at the initial visit.
Patients will have erythema of the arytenoids and posterior commissure, which may extend to the true and false vocal cords, subglottic mucosa, and pharyngeal mucosa. The interarytenoid space will exhibit mucosal hypertrophy. In advanced cases, the posterior commissure will have hyperkeratotic epithelium. Vocal cord granulomas occur at the vocal process at the arytenoid cartilage. Because of the posterior position of the vocal process, they are greatly influenced by reflux. Vocal cord nodules are likely a result of untreated LPR in an adult and are seen bilaterally at the junction of the anterior and middle thirds of the phonating surface of the true vocal cords. Laryngeal stenosis is a severe consequence of ongoing LPR and may be life-threatening. Affected patients generally have a traumatized larynx, most often from direct trauma or intubation injury. Seventy-five percent of patients with diagnosed laryngeal and tracheal stenosis demonstrate significant reflux. 8 Videostroboscopy is a video examination of the larynx using a rigid fiberoptic endoscope with an intermittent xenon light source that is activated by vocal fold movement. The video examination allows enlarged, slow-motion visualization of the vocal cords. Using playback, the clinician can study and document vibratory motion and laryngeal problems that cannot otherwise by appreciated. This technology is available for use in an office setting without anesthesia. 9 Direct visualization of the vocal cords also enhances patient education. An acoustic voice evaluation, performed by a speech therapist, often adds a collaborative approach to the videostroboscopy, Barium esophagography is for patients who are suspected of having GERD or LPR. This radiographic study will identify motility and peristaltic abnormalities, esophageal lesions, spontaneous reflux, hiatal hernia, and lower esophageal sphincter disorders. Although barium esophagoscopy is less sensitive in diagnosing LPR, it is advisable for a complete workup when treatment fails or it is otherwise clinically indicated, such as in patients who have signs of GERD, esophageal dysfunction, or an unclear diagnosis. Ambulatory pH monitoring has been used extensively in the stuffy of GERD and LPR. This test is invasive and uncomfortable for most patients. At present, it is not routinely used in the initial evaluation of LPR, but it may be useful in the diagnosis of laryngeal stenosis and paroxysmal laryngeal spasm or for patients whose symptoms do not resolve with treatment. continues to have symptoms of LPR but the findings from the initial workup are negative, ambulatory, 24-hour, double-probe pH monitoring is till the gold standard for the diagnosis. Direct laryngoscopy (and suspension microlaryngoscopy, which is the same procedure using different equipment) is performed under general anesthesia, usually by an otolaryngologist. This method allows superior or visualization of the larynx and surrounding structures, and it also permits biopsy of vocal cord lesions.
Treatment
Proton pump inhibitors (PPIs) and H 2 -receptor antagonists are the mainstay of treatment for LPR as well as GERD. Treatment of LPR depends on severity of symptoms, but in general LPR requires a more aggressive, longer course of therapy than does GERD. Mild symptoms may be treated with H 2 -receptor antagonists and dietary and lifestyle modifications. Patient education regarding precautions to prevent reflux is the key to success. Half of patients with mile LPR will have resolution of symptoms with the indicated lifestyle changes. 10 Most patients with moderate to severe LPR on examination will require at least twice daily dosing with a PPI because none of the PPIs suppresses acid for more than 16.8 hours 1 and laryngeal damage may occur with as few as three intermittent LPR episodes a week. 3, 4 Most patients will report significant improvement in symptoms within 2 to 3 months after treatment is initiated; however, studies show that healing takes 6 months or longer. 4, 5 Twice daily dosing of a PPI for a minimum of 6 months is recommended to reverse tissue injury in the larynx. Approximately 20% to 30% of patients do not respond to the standard regimen of twice-daily dosing with a PPI. 3, 11 A subgroup of patients may require prolonged or lifetime treatment if their symptoms recur when they stop the medication. Follow-up examinations should be scheduled every 3 months to monitor symptoms or more often if the disease is not responding to treatment or the patient has new symptoms. Patients with persistent symptoms and laryngeal changes should undergo further workup.
